# Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

> **NCT03610945** · PHASE1 · COMPLETED · sponsor: **Enanta Pharmaceuticals, Inc** · enrollment: 48 (actual)

## Conditions studied

- NASH - Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Quinidine
- **DRUG:** EDP-305
- **DRUG:** EDP-305

## Key facts

- **NCT ID:** NCT03610945
- **Lead sponsor:** Enanta Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-19
- **Primary completion:** 2018-08-15
- **Final completion:** 2018-08-21
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03610945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03610945, "Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03610945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*